Antitumor efficacy of the novel poly(ADP-ribose) polymerase (PARP-1) inhibitor BSI-401 and synergism with oxaliplatin (OX) in an orthotopic murine model of pancreatic cancer (PC)
Antitumor efficacy of the novel poly(ADP-ribose) polymerase (PARP-1) inhibitor BSI-401 and synergism with oxaliplatin (OX) in an orthotopic murine model of pancreatic cancer (PC)
MELISI, Davide;
2009-01-01
Abstract
Antitumor efficacy of the novel poly(ADP-ribose) polymerase (PARP-1) inhibitor BSI-401 and synergism with oxaliplatin (OX) in an orthotopic murine model of pancreatic cancer (PC)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
